Articles tagged "Outcome"

2018 American Transplant Congress
Post‐Donation eGFR Levels Predicts New‐Onset Antihypertensive Medication Use after Living Kidney Donation
K. Lentine,¹ D. Segev,² N. Lam,³ A. Garg,⁴ A. Naik,⁵ D. Axelrod,⁶ H. Xiao,¹ M. Henderson,² A. Massie,² B. Kasiske,⁷ G. Hess,⁸ C. Hsu,⁹ D. Brennan,² M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Johns Hopkins, Baltimore; ³Univ Alberta, Edmonton, Canada; ⁴Western Univ, Ontario, Canada; ⁵Univ Michigan, Ann Arbor; ⁶Lahey Clinic, Burlington; ⁷Hennepin County, Minneapolis; ⁸Symphony Health, Conshohocken; ⁹UCSF, San Francisco.
Limited data are available on the outcome implications of renal function after living kidney donation.We constructed a novel database linking SRTR registry identifiers, serum creatinine…
2018 American Transplant Congress
A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes
J. Friedewald,¹ S. Kurian,² T. Whisenant,² R. Heilman,³ E. Poggio,⁴ C. Marsh,² P. Baliga,⁵ N. Bridges,⁶ J. Odim,⁶ M. Brown,⁶ D. Ikle,⁷ B. Armstrong,⁷ J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ L. Zhao,¹ M. Kandpal,¹ D. Salomon,² M. Abecassis.¹
¹Northwestern Medicine, Chicago; ²Scripps, La Jolla; ³Mayo AZ, Scottsdale; ⁴Cleveland Clinic, Cleveland; ⁵MUSC, Charleston; ⁶NIAID, Bethesda; ⁷Rho, Chapel Hill.
BACKGROUNDSub-clinical acute rejection (subAR) in kidney transplant recipients (KTR), defined as histological rejection on surveillance biopsy (Bx) in a patient with stable renal function, signals…
2018 American Transplant Congress
Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period
A. Metry, I. Al Salmi, F. Al Ismaili, A. Hola, F. Shaheen, I. Al Salmi.
The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; SCOT, SCOT, Riyadh, Saudi Arabia; The Renal Medicine, The Royal Hospital, Muscat, Oman.
USRDS showed that 1.2% & 1.6% incidences of tuberculosis-TB in patients on peritoneal dialysis and hemodialysis-HD, respectively. Kidney transplant-KTX patients have higher rates.We studied the…
2018 American Transplant Congress
Liver Allocation: One OPO's Experience with Expedited versus Non-Expedited Placement
C. Muse, R. Squires, C. Trahan, J. Whaley, J. Orlowski.
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK.
Background: One organ procurement organization (OPO) sought to study expedited versus non-expedited livers recovered/transplanted after local/regional centers declined. The OPO sought to determine relative recipient…
2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health BIH, Charite and Max Delbrueck Center, Berlin, Germany.
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…
2018 American Transplant Congress
Heart Transplantation in Patients with Complex Congenital Heart Disease
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa, R. Garg, E. Zahn.
Cedars Sinai Medical Center, Los Angeles.
Purpose: As medical and surgical management of complex congenital heart disease (CCHD) improves, patients may survive into adulthood to suffer from end-stage heart failure and…
2018 American Transplant Congress
A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study
F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.
Department of Nephrology and Medical Intensive Care, Charité University Berlin, Berlin, Germany.
Background: Non-adherence to medication is one of the leading problems for poor long-term outcome in kidney transplant recipients (KTR). Here we analyze the impact of…
2018 American Transplant Congress
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease
E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
NYU Langone Medical Center, New York, NY.
Objective: Peripheral vascular disease (PVD) is common among end-stage renal disease (ESRD) patients and is a known independent risk factor for increased post-transplant mortality. The…
2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
¹Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI; ²Department of Anesthesia, Medical College of Wisconsin, Milwaukee, WI; ³Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI; ⁴Department of Medicine, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…
2018 American Transplant Congress
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review
Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Transplant Infectious Diseases, UHN, Toronto, ON, Canada.
Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…